Bridge Biotherapeutics, Inc. (KOSDAQ:288330)
South Korea · Delayed Price · Currency is KRW 2,865.00
+95.00 (3.43%)
At close: Jul 18, 2025, 3:30 PM KST
Bridge Biotherapeutics Market Cap
Bridge Biotherapeutics has a market cap or net worth of 149.53 billion as of July 18, 2025. Its market cap has increased by 199.50% in one year.
Market Cap
149.53B
Enterprise Value
135.22B
Revenue
11.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,865.00
Market Cap Chart
Since December 20, 2019, Bridge Biotherapeutics's market cap has decreased from 300.15B to 149.53B, a decrease of -50.18%. That is a compound annual growth rate of -11.74%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 438.76T |
| SK hynix | 185.70T |
| LG Energy Solution | 75.47T |
| Samsung Biologics | 74.80T |
| Hyundai Motor Company | 46.02T |
| Hanwha Aerospace | 42.27T |
| Doosan Enerbility | 41.50T |
| KB Financial Group | 41.29T |